IDO1 and colonic neoplasm: Compared with miR-448high colon cancer patients, IDO1 level will be elevated faster in these miR-448low colon cancer patients when they receive T cell related therapy (CAR-T, anti-PD-1) due to the lack of endogenous miR-448 inhibition to IDO1.